Amiodarone
Amiodarone is a medication used in the treatment of various types of tachyarrhythmia, an abnormal fast rhythm of the heart. It is a class III antiarrhythmic agent and is used in situations where other medications are either not effective or are contraindicated.
Pharmacology
Amiodarone works by prolonging the duration of the action potential of cardiac tissue and by prolonging the refractory period of the heart's electrical conduction system. It achieves this by inhibiting potassium channels, which are responsible for repolarization of the heart following a heartbeat. This results in a slowing of the heart rate and a reduction in the occurrence of abnormal heart rhythms.
Medical uses
Amiodarone is primarily used to treat a variety of heart rhythm disorders such as ventricular tachycardia and ventricular fibrillation. It is also used in the treatment of wide complex tachycardia, as well as atrial fibrillation and paroxysmal supraventricular tachycardia. It is often used when other medications have failed to control the heart rhythm disorder.
Side effects
The use of Amiodarone can be associated with several side effects. These can include nausea, vomiting, constipation, and anorexia. More serious side effects can include pulmonary toxicity, thyroid dysfunction, and liver toxicity. Due to these potential side effects, monitoring is required during treatment with Amiodarone.
History
Amiodarone was initially developed in 1961 in Belgium. It was initially used as a treatment for angina, but its antiarrhythmic properties were discovered by chance. It was approved for medical use in the United States in 1985.
See also
List of antiarrhythmic agents:
- Amiodarone
- Disopyramide
- Dofetilide
- Dronedarone
- Flecainide
- Ivabradine
- Mexiletine
- Procainamide
- Propafenone
- Quinidine
Emergency medicine | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
|
Lua error in package.lua at line 80: module 'strict' not found.
Monoamine reuptake inhibitors | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD